|
|
|
|
Influence of immunocorrection on the inflammatory process in the urogenital tract in men with infertility
Tsiporenko SIu
Lugansk State Medical University, Lugansk, Ukraine
DOI: https://doi.org/10.15407/fz59.06.072
Abstract
We studied the concentration of metalloproteinases, pro-and anti-inflammatory cytokines, lymphocyte activation markers in seminal plasma of men with oligosymptomatic forms of chronic inflammation of the urogenital tract complicated with infertility. It was shown that chronic inflammation of the urogenital tract shifts the levels of cytokine profile, reduces the concentration of metalloproteinase-2 (576.4 +/- 89.3 ng/ml, P < 0.001), chemokines - fractalkine (16.3 +/- 1.3 pg/ml, P < 0.001) and chemmmokine regulated by activation, expression and secretion of normal T-cells (RANTES (12.7 +/- 1.0 pg/ ml, P < 0.001). Additionally, we observed a sharp increase in IL-8 (215.5 +/- 7.8 pg/ml, P < 0.01), MCP-1 (926.4 +/- 30.2 pg/ml, P < 0.001) and elevation of the CD25 + / CD95 + ratio. These observations point for alterations in apoptotic mechanisms in pathological forms of the generative cells and their accumulation in the sperm. Prolonged inflammation of the genital area is accompanied by depletion of the local immune system resulting in the development of infertility. The multidirectional shifts in IL-10/IL-12 index have been established: an increase in the group of patients with elevated level of hypercapitated spermatozoa and its reduction in microsomatic morphotype of spermatozoa. These data emphasize the importance of the microenvironment in maturation of gametes. It was shown that an inclusion of alfagin and gepatomax in immunorehabilitation of men with oligosymptomatic forms of urogenital infections improves leukocyte subpopulation content of sperm and concentrations of pro-and anti-inflammatory cytokines, and therefore, results in an increase in fertilizing potential.
Keywords:
male infertility, sperm, seminal plasma, metalloproteinases, cytokine profile, immunorehabilitation, alfagin, hepatomax.
References
- Lyah Yu.E., Gur'yanov V.G. Osnovi komp'yuternoi biostatistiki: analiz informatsii v biologii, meditsine ifarmatsii statisticheskim paketom. Donetsk: MedStat, 2004. 212 s.
- Orlova L., Petrov S. Aktivnist' metaloproteinazimatriksu (MMR-2) i katepsinopodibnoi proteinaziD u riznih vidiv zmii . Visnik L'viv. un-tu. 2011. N 55. S. 34-38.
- Poryadin G.V., Salmasi Zh. M., Kazimirskii A. N. Aktivatsionnie markeri limfotsitov kak pokazatelidisregulyatsii immunnoi sistemi pri vospalenii .Patologiya i terapiya. 2006. N 2. S. 2-7.
- Baumgart E., Lenk S,V., Loening S.A., Jung K. Quantitativedifferences in matrix metalloproteinase (MMP)-2, but not inMMP-9, tissue inhibitor of metalloproteinase (TIMP)-1 or TIMP-2, in seminal plasma of normozoospermic and azoospermicpatients . Hum. Reprod. 2002. N 17. R. 2919-2923.
- Benjamin M.M., Khalil R.A. Matrix metalloproteinase inhibitorsas investigative tools in the pathogenesis and managementof vascular disease . EXS. 2012. 103. P. 209-279.
CrossRef
PubMed PubMedCentral
- Elkington, P.T., O'Kane, C.M., Friedland, J.S. The paradoxof matrix metalloproteinases in infectious disease . Clin.Exp. Immunol. 2005. 142. P. 12-20.
CrossRef
PubMed PubMedCentral
- Jedinak A., Maliar T. Inhibitors of proteases as anticancerdrugs . Neoplasma. 2005. 52. P. 185-192.
PubMed
- Jennifer R., Fang Li, Xiaobei Zhang. ELR-CXC chemokinereceptor antagonism targets inflammatory responses atmultiple levels . J. Immun. 2009. 182. P. 3213-3222.
CrossRef
PubMed
- Loetscher, P., Clark-Lewis, I. Agonistic and antagonisticactivities of chemokines . J. Leukoc. Biol. 2001. 69. P. 881-884.
PubMed
- Marquez-Curtis L.A., Shirvaikar N., Robert Turner A., MirzaI. Membrane type-1 matrix metalloproteinase expressionin acute myeloid leukemia and its upregulation by tumornecrosis factor-? . Cancers. 2012. 4. P. 743-762.
CrossRef
PubMed PubMedCentral
- McCauley T.C., Zhang H.M., Bellin M.E., Ax R.L.Identification of a heparin-binding protein in bovineseminal fluid as tissue inhibitor of metalloproteinases-2.Mol . Reprod. Dev. 2001. 58. P. 336-341.
CrossRef
- Pal S., Ganguly K.K., Chatterjee A. Extracellular matrixprotein fibronectin induces matrix metalloproteinases inhuman prostate adenocarcinoma cells PC-3 . Cell Commun.Adhes. 2013. 20(5). P. 105-114.
CrossRef
PubMed
- Papanicolaou G.N. New cancer diagnosis. Proceedingsof the Third Race Betterment Conference, January 1928.Race Betterment Foundation, Battle Creek, Michigan. 1928. P. 528-534.
- Seshadri S., Bates M., Vince G., Lewis Jones D. I.Cytokine expression in the seminal plasma and its effectson fertilisation rates in an IVF cycle . Andrologia. 2011. 43. P. 378-386.
CrossRef
PubMed
- Van den Steen P.E., Proost P., Wuyts A., Van DammeJ., Opdenakker G. Neutrophil gelatinase B potentiatesinterleukin-8 tenfold by aminoterminal processing, whereasit degrades CTAP-III, PF-4, and GRO-? and leaves RANTESand MCP-2 intact . Blood. 2001. 96. P. 2673-2681.
- WHO laboratory manual for the examination of humansperm and semem-cervical mucus interaction. WHO,4-th edn.: Cambridge universiti press, 1999. P. 128.
- Zakosek Pipan M., Kosec M., Mrkun J., Zrimsek P. Gelatinasesin boar seminal plasma and their relation to semenindicators . Acta Vet. 2010. 79. P .491-496.
- Zhang X., Ibrahim E., de Rivero Vaccari J.P., Lotocki G.,Aballa T.C. Involvement of the inflammasome in abnormalsemen quality of men with spinal cord injury . Fertil.Steril. 2013. 99. P. 118-124.
CrossRef
PubMed
|
|
|
|
|
|
|